Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
C-MER Eye Care Holdings Limited ( (HK:3309) ) just unveiled an announcement.
C-MER Eye Care Holdings Limited has signed an agreement with HKO to transfer its 55% equity interest in Apollo back to HKO. The transaction involves the cancellation of a bond previously issued as part of Apollo’s acquisition. With this disposal, Apollo will no longer remain a subsidiary of the company. The move reflects C-MER’s strategy to streamline resources and focus on its core healthcare businesses, including ophthalmology and dental services, in key markets. The Directors have confirmed the transaction aligns with commercial fairness and the interests of the company’s stakeholders, potentially strengthening its operational focus and financial efficiency.
The most recent analyst rating on (HK:3309) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on C-MER Eye Care Holdings Limited stock, see the HK:3309 Stock Forecast page.
More about C-MER Eye Care Holdings Limited
C-MER Eye Care Holdings Limited is a company operating in the medical industry, with a focus on providing ophthalmic services in Hong Kong and Mainland China, as well as dental and medical services in Shenzhen. The company has been actively optimizing its strategic resources to align with its market objectives.
Average Trading Volume: 528,035
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.92B
See more data about 3309 stock on TipRanks’ Stock Analysis page.